Clinical Trials · NCT07128082
The Long COVID Treatment Trial
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Scripps Translational Science Institute
- Enrollment
- 1,000
- Start date
- Oct 2025
- Locations
- 1 site, United States
- Primary endpoint
- Primary Objective 1: Changes in fatigue severity score, measured by Fatigue Severity Scale (FSS)